Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学T-DXd Breast Cancer

Sara Hurvitz

MD

🏢University of California, Los Angeles🌐USA

Professor of Medicine, Director of Breast Cancer Clinical Trials

65
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Sara Hurvitz is a leading breast cancer clinical trialist who has been an important investigator in trastuzumab deruxtecan trials across multiple settings. Her work spans early and metastatic breast cancer, optimizing both HER2-targeted and endocrine-based therapies. She leads a large breast cancer clinical trials program advancing novel combination strategies.

Share:

🧪Research Fields 研究领域

Breast cancer
HER2-positive therapy
Trastuzumab deruxtecan
CDK4/6 inhibitors
Early breast cancer

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Sara Hurvitz 的研究动态

Follow Sara Hurvitz's research updates

留下邮箱,当我们发布与 Sara Hurvitz(University of California, Los Angeles)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment